MAPT and Alzheimer disease: In agreement, further results have shown that geniposide counteracts the increase of Tau phosphorylation induced by the insulin deficiency in AD mice treated with STZ, by promoting GSK-3β phosphorylation and subsequent inactivation (Zhang et al., 2015).